Somerville, MA, United States of America

Jordi Mata-Fink

USPTO Granted Patents = 26 

 

Average Co-Inventor Count = 5.8

ph-index = 8

Forward Citations = 260(Granted Patents)


Location History:

  • Happy Valley, OR (US) (2021)
  • Somerville, MA (US) (2017 - 2023)
  • Baltimore, MD (US) (2019 - 2023)

Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: The Innovative Journey of Jordi Mata-Fink

Introduction: Jordi Mata-Fink is an accomplished inventor based in Somerville, MA, known for his significant contributions to the field of immunology. With 26 patents to his name, he has made considerable strides in developing methods and compositions aimed at immunomodulation, showcasing his dedication to advancing medical science.

Latest Patents: Among his latest innovations, Jordi has worked on groundbreaking patents titled "Methods and compositions for immunomodulation - Provided are cells containing exogenous antigen and uses thereof." These patents represent a vital step forward in exploring how specific cells can be utilized to modulate immune responses, potentially leading to improved therapeutic applications.

Career Highlights: Jordi Mata-Fink's career features prominent roles at notable companies such as Rubius Therapeutics, Inc. and Flagship Pioneering Innovations V, Inc. His expertise in the biotech sector has paved the way for advancements in immunomodulatory strategies, emphasizing his role as a leading figure in this area of research.

Collaborations: Throughout his career, Jordi has collaborated with esteemed colleagues including Avak Kahvejian and John Round. These partnerships reflect his commitment to teamwork and innovation, fostering an environment where groundbreaking ideas can thrive.

Conclusion: Jordi Mata-Fink stands out as a significant inventor in the realm of immunology. His extensive patent portfolio and collaborative efforts underscore his impact on the industry. With a focus on advancing immunomodulation techniques, he continues to contribute to meaningful innovations that may improve healthcare outcomes for many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…